Product image of Katul Continuous (Drospirenone, Ethinylestradiol | Lactose Anhydrous) supplied by GNH India

Katul Continuous

Active Ingredient:
Drospirenone, Ethinylestradiol | Lactose Anhydrous
Origin:
EU

Katul Continuous (Drospirenone, Ethinylestradiol | Lactose Anhydrous)

Drospirenone, the active ingredient in Katul Continuous, is a combined oral contraceptive presented as a tablet for oral use. Together with ethinylestradiol, it provides hormonal contraception and helps regulate menstrual cycles in women of reproductive age. It is prescribed for reliable birth control and cycle management.

GNH India supplies Katul Continuous as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Customers benefit from reliable supply chains and responsive technical support.

Manufacturer / TM Owner

Gedeon Richter Plc.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Katul Continuous, a combined oral contraceptive, is used to prevent pregnancy and manage menstrual cycle disorders.

  • Contraception: provides reliable hormonal birth control to prevent ovulation.
  • Irregular menstrual cycles: helps establish regular cycle length and flow.
  • Menstrual-related symptoms: reduces dysmenorrhea and premenstrual discomfort.

How It Works

  • Drospirenone acts as a progestogenic agent with anti‑mineralocorticoid activity, while ethinylestradiol provides estrogenic effects. Together they suppress the hypothalamic‑pituitary‑gonadal axis, reducing luteinizing hormone (LH) and follicle‑stimulating hormone (FSH) release, thereby inhibiting ovulation. The combination also thickens cervical mucus and induces endometrial changes that decrease the likelihood of implantation.

Side Effects

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Breast tenderness: discomfort or swelling of the breasts.
  • Headache: occasional mild to moderate pain.
  • Weight gain: slight increase in body weight.
  • Mood changes: irritability or emotional fluctuations.
  • Spotting: irregular light bleeding between periods.

Serious or Rare Side Effects

  • Venous thromboembolism: blood clots in deep veins or lungs.
  • Hypertension: significant increase in blood pressure.
  • Hepatic adenoma: benign liver tumor.
  • Gallbladder disease: inflammation or stones.
  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Severe depression or suicidal thoughts.

Precautions & Warnings

Before starting Katul Continuous, consider the following precautions:

  • Pregnancy contraindication: must not be used during pregnancy.
  • Smoking restriction: avoid smoking if over 35 years of age.
  • Cardiovascular risk: assess history of thromboembolic events.
  • Blood pressure monitoring: check regularly during therapy.
  • Liver disease: evaluate hepatic function before use.
  • Missed dose guidance: follow specific instructions for forgotten tablets.
  • Store below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Katul Continuous may interact with other medicines as follows:

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): reduce contraceptive effectiveness.
  • Certain antivirals (e.g., efavirenz): may lower hormone levels.
  • St. John’s wort: can diminish contraceptive protection.

Moderate Interactions (Monitor Closely)

  • Antifungals (e.g., ketoconazole): may increase hormone exposure.
  • Some antibiotics (e.g., clarithromycin): monitor for breakthrough bleeding.
  • SSRIs: may affect bleeding patterns.
  • Antihypertensives: additive blood pressure effects.
  • Herbal supplements (e.g., ginseng): watch for reduced efficacy.

Frequently Asked Questions

Katul Continuous is a combined oral contraceptive containing drospirenone and ethinylestradiol. It is prescribed to prevent pregnancy and to help regulate menstrual cycles, providing reliable birth control and improving cycle consistency for women of reproductive age.

Drospirenone acts as a progestin with anti‑mineralocorticoid properties, while ethinylestradiol supplies estrogenic activity. Together they suppress the release of luteinizing hormone and follicle‑stimulating hormone, preventing ovulation, thickening cervical mucus, and altering the endometrium to reduce the chance of implantation.

The dosing regimen for Katul Continuous is determined by the prescribing healthcare professional. Typically, the product is taken once daily at the same time each day, but the exact schedule and any missed‑dose instructions should follow the prescriber’s guidance.

Katul Continuous is contraindicated in pregnancy and should not be used by women who are pregnant or planning to become pregnant. It is also not recommended during breastfeeding because hormonal contraceptives can affect milk production and infant exposure.

To order Katul Continuous, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Katul Continuous contains drospirenone, which offers anti‑mineralocorticoid activity that may reduce water retention compared with some other progestins. Its efficacy in preventing pregnancy is comparable to other combined oral contraceptives, while the side‑effect profile may differ slightly, especially regarding weight and blood pressure effects.

Katul Continuous tablets should be stored below 25 °C in their original packaging, protected from moisture and direct sunlight. Keep the container tightly closed and out of reach of children to maintain product stability and potency.

Katul Continuous is taken orally as a tablet, usually once each day at the same time. The tablets are swallowed with water and should be taken with or without food, following the prescriber’s instructions for any missed doses.

The most serious risks include venous thromboembolism, severe hypertension, hepatic adenoma, and rare but severe allergic reactions. Women with a history of blood clots, uncontrolled hypertension, or liver disease should discuss these risks with their healthcare provider before starting therapy.

Katul Continuous should not be used by women who are pregnant, have a known hypersensitivity to any component, have a history of thromboembolic disorders, uncontrolled hypertension, certain liver diseases, or who smoke heavily and are over 35 years of age.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Drospirenone, Ethinylestradiol | Lactose Anhydrous

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT